Teladoc SVP Dr. Alan Roga to present at 24th Annual Health Forum and American Hospital Association Leadership Summit

LEWISVILLE, Texas (July 15, 2016) — Teladoc, Inc. (NYSE: TDOC), the first and largest telehealth platform in the United States, announced that Alan Roga, MD, FACEP, Teladoc senior vice president and general manager, provider market, will address the topic of telehealth for hospitals and health systems at the upcoming 24th Annual Health Forum and American Hospital Association Leadership Summit in San Diego, Calif.

Dr. Roga's presentation, "How to Align Telehealth as a Strategic Asset," is among the Innovator's Connection presentations at the Leadership Summit Exhibit Hall on Sunday, July 17, at 5:40 p.m. Dr. Roga will speak to the trends driving telehealth adoption— including consumer demand, changing reimbursement models and proven results—and key considerations in developing a telehealth strategy.

Additionally, Dr. Roga will present "Telehealth: Top Health System Trends and Challenges" at a hosted breakfast session on Monday, July 18, from 7:30 8:30 a.m. in the Hillcrest AB room of the Manchester Grand Hyatt. Attendees also are invited to visit Teladoc in the exhibit hall at Booth #403.

About Teladoc

Teladoc, Inc. (NYSE:TDOC) is the nation's leading provider of telehealth services and a pioneering force in bringing the virtual care visit into the mainstream of today's health care ecosystem. Serving some 6,000 clients — including health plans, health systems, employers and other organizations — more than 15 million members can use phone, mobile devices and secure online video to connect within minutes to Teladoc's network of more than 3,000 board-certified, state-licensed physicians and behavioral health specialists, 24/7. With national coverage, a robust, scalable platform and a Lewisville, Texas-based member services center staffed by 400 employees, Teladoc offers the industry's most comprehensive and complete telehealth solution including primary care, behavioral health care, dermatology, tobacco cessation and more. For additional information, please visit